Haemonetics Ownership | Who Owns Haemonetics?


OverviewForecastRevenueFinancialsChartTranscripts

Haemonetics Ownership Summary


Haemonetics is owned by 30.82% institutional investors, 1.19% insiders, and 67.99% retail investors. Blackrock funding, inc. /de is the largest institutional shareholder, holding 12.01% of HAE shares. Neuberger Berman Genesis Inv is the top mutual fund, with 4.39% of its assets in Haemonetics shares.

HAE Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockHaemonetics30.82%1.19%67.99%
SectorHealthcare Stocks 35.58%11.87%52.55%
IndustryMedical Instruments & Supplies Stocks35.51%13.37%51.13%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Blackrock funding, inc. /de5.62M12.01%$316.74M
Blackrock5.96M11.73%$493.00M
Vanguard group4.76M10.18%$381.60M
Neuberger berman group3.56M7.61%$200.61M
Aqr capital management3.36M7.17%$185.68M
State street1.77M3.79%$99.92M
Arrowstreet capital, limited partnership1.38M2.96%$77.95M
River road asset management1.33M2.84%$74.85M
Dimensional fund advisors lp1.33M2.83%$74.73M
Fmr1.28M2.73%$71.91M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
North peak capital management998.95K9.36%$56.30M
Kestrel investment management97.40K3.28%$5.49M
Expect equity37.03K2.00%$2.09M
Sio capital management220.67K1.78%$12.44M
Invenomic capital management lp664.73K1.72%$37.46M
Qsv equity investors14.03K1.66%$1.12M
Aristotle capital boston346.39K1.21%$19.55M
Riverwater partners46.05K0.87%$2.60M
River road asset management1.33M0.85%$74.85M
Beacon investment advisors37.12K0.79%$2.09M

Top Buyers

HolderShares% AssetsChange
Invenomic capital management lp664.73K1.72%664.73K
Man group503.12K0.04%341.30K
Vanguard fiduciary trust323.58K0.00%323.58K
Qube research430.15K0.03%294.37K
Boston partners556.68K0.03%234.01K

Top Sellers

HolderShares% AssetsChange
Holocene advisors, lp4.52K0.00%-1.26M
Capital research global investors---1.14M
Citadel advisors258.15K0.00%-1.03M
Sg capital management---906.89K
Westfield capital management co lp---805.92K

New Positions

HolderShares% AssetsChangeValue
Vanguard fiduciary trust323.58K0.00%323.58K$18.24M
Norges bank125.93K0.00%125.93K$10.09M
Jupiter asset management115.09K0.03%115.09K$6.49M
Healthcare of ontario pension plan trust fund114.28K0.01%114.28K$6.44M
Weiss asset management lp107.66K0.06%107.66K$5.25M

Sold Out

HolderChange
Colonial trust co / sc-1.00
Dunhill financial-1.00
Rfp financial group-1.00
Tfc financial management-1.00
Hughes financial services-1.00

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Mar 31, 2026157-54.62%14,419,965-71.66%300.26%81-51.20%50-63.50%
Dec 31, 2025236-24.84%33,122,441-35.46%700.62%108-32.08%94-16.81%
Sep 30, 2025206-32.01%35,258,051-32.80%730.62%91-41.29%88-13.73%
Jun 30, 2025309-6.93%54,411,7830.83%1130.98%158-12.22%103-
Mar 31, 2025330-0.30%53,955,084-5.19%1070.84%1804.05%1027.37%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
Neuberger Berman Genesis Inv2.11M4.39%-80.85K
iShares Core S&P Mid-Cap ETF1.57M3.37%-784.00
Vanguard Total Stock Mkt Idx Inv1.49M3.30%4.68K
Vanguard US Total Market Shares ETF1.60M3.19%1.18K
Neuberger Genesis Inv1.22M2.63%-193.85K
Vanguard Explorer Inv1.18M2.46%-
iShares Russell 2000 ETF1.11M2.38%9.35K
Vanguard Small Cap Index1.07M2.37%-1.81K
T. Rowe Price US Smlr Cm Eq A USD1.06M2.22%-54.63K
American Funds SMALLCAP World A1.01M2.11%-374.17K

Recent Insider Transactions


DateNameRoleActivityValue
Nov 10, 2025KROLL MARK W-Buy$98.78K
Jul 26, 2024Strong Stewart W President, Global HospitalSell$393.04K
Jul 12, 2024Lingamneni Anila EVP, Chief Technology OfficerSell$7.11K
Jul 11, 2024Lingamneni Anila EVP, Chief Technology OfficerSell$192.24K
May 29, 2024Basil Michelle L EVP and General CounselSell$362.61K

Insider Transactions Trends


DateBuySell
2025 Q41-
2025 Q3--
2025 Q2--
2024 Q4--
2024 Q3-3

HAE Ownership FAQ


Who Owns Haemonetics?

Haemonetics shareholders are primarily institutional investors at 30.82%, followed by 1.19% insiders and 67.99% retail investors. The average institutional ownership in Haemonetics's industry, Medical Instruments & Supplies Stocks, is 35.51%, which Haemonetics falls below.

Who owns the most shares of Haemonetics?

Haemonetics’s largest shareholders are Blackrock funding, inc. /de (5.62M shares, 12.01%), Blackrock (5.96M shares, 11.73%), and Vanguard group (4.76M shares, 10.18%). Together, they hold 33.92% of Haemonetics’s total shares outstanding.

Does Blackrock own Haemonetics?

Yes, BlackRock owns 11.73% of Haemonetics, totaling 5.96M shares as of Jun 2024. This represents 0.01% of BlackRock's total assets, with a market value of 493M$. In the last quarter, BlackRock decreased its holdings by -25.268K shares, a -0.42% change.

Who is Haemonetics’s biggest shareholder by percentage of total assets invested?

North peak capital management is Haemonetics’s biggest shareholder by percentage of total assets invested, with 9.36% of its assets in 998.95K Haemonetics shares, valued at 56.3M$.

Who is the top mutual fund holder of Haemonetics shares?

Neuberger Berman Genesis Inv is the top mutual fund holder of Haemonetics shares, with 4.39% of its total shares outstanding invested in 2.11M Haemonetics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools